ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO, NCCS form cancer quality alliance.

November 11, 2005

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

June 21, 2013

Armstrong Foundation To Fund Studies In Testicular Cancer

April 17, 1998

In The States: Illinois, Virginia approve Legislation Mandating Coverage of Care In Cancer Clinical Trials

June 4, 1999

Historical Vs. Current Controls: Comparability, Ethical Issues Argued By Moertel, Freireich

April 20, 1979

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004